Literature DB >> 22810421

p68 RNA helicase promotes glioma cell proliferation in vitro and in vivo via direct regulation of NF-κB transcription factor p50.

Rui Wang1, Zhuomin Jiao, Ruiyan Li, Hui Yue, Lijie Chen.   

Abstract

The DEAD-box RNA helicase p68 plays a very important role in early organ development and maturation. However, the role of p68 in glioma is unclear. In this study, we showed that p68 protein levels were significantly elevated in high-grade gliomas compared to low-grade gliomas and normal adjacent brain tissues. Importantly, the expression of p68 was significantly associated with poorer overall survival and enhanced resistance to treatment with radiotherapy plus temozolomide for glioma patients. Ectopic expression of p68 enhanced glioma cell proliferation both in vitro and in vivo. In contrast, knockdown of endogenous p68 prevented glioma cell proliferation. Using a tandem affinity purification assay, we found a new p68-binding protein, nuclear factor (NF)-κB p50. We found that p68 bound with the N-terminal of NF-κB p50, and the mutant of p68 lacking the p50-interaction domain failed to stimulate glioma cell proliferation and tumor growth. Moreover, p68 induced NF-κB p50 accumulation in the nucleus through release of NF-κB p50 from IκBα and increased NF-κB p50 target luciferase transcription activity. Knockdown of NF-κB p50 rescued the phenotypes induced by p68 both in vitro and in vivo. We concluded that p68 induces glioma tumor growth through binding with NF-κB p50, regulating NF-κB p50 nucleus accumulation and transcription activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22810421      PMCID: PMC3424208          DOI: 10.1093/neuonc/nos131

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  34 in total

1.  p68, a DEAD-box RNA helicase, is expressed in chordate embryo neural and mesodermal tissues.

Authors:  D W Seufert; R Kos; C A Erickson; B J Swalla
Journal:  J Exp Zool       Date:  2000-10-15

2.  p68 RNA helicase is an essential human splicing factor that acts at the U1 snRNA-5' splice site duplex.

Authors:  Zhi-Ren Liu
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

3.  Overexpression and poly-ubiquitylation of the DEAD-box RNA helicase p68 in colorectal tumours.

Authors:  M Causevic; R G Hislop; N M Kernohan; F A Carey; R A Kay; R J Steele; F V Fuller-Pace
Journal:  Oncogene       Date:  2001-11-22       Impact factor: 9.867

4.  Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential.

Authors:  Steven M Mooney; Joseph P Grande; Jeffrey L Salisbury; Ralf Janknecht
Journal:  Biochemistry       Date:  2010-01-12       Impact factor: 3.162

5.  Absence of Dbp2p alters both nonsense-mediated mRNA decay and rRNA processing.

Authors:  A T Bond; D A Mangus; F He; A Jacobson
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

6.  NF-kappaB p50-deficient mice show reduced anxiety-like behaviors in tests of exploratory drive and anxiety.

Authors:  Cheryl A Kassed; Miles Herkenham
Journal:  Behav Brain Res       Date:  2004-10-05       Impact factor: 3.332

7.  Constitutive nuclear factor-kappa B activity is required for central neuron survival.

Authors:  Asha L Bhakar; Laura-Lee Tannis; Christine Zeindler; Maria Pia Russo; Christian Jobin; David S Park; Sandra MacPherson; Philip A Barker
Journal:  J Neurosci       Date:  2002-10-01       Impact factor: 6.167

8.  Lack of NF-kappaB p50 exacerbates degeneration of hippocampal neurons after chemical exposure and impairs learning.

Authors:  C A Kassed; A E Willing; S Garbuzova-Davis; P R Sanberg; K R Pennypacker
Journal:  Exp Neurol       Date:  2002-08       Impact factor: 5.330

Review 9.  NF-kappaB regulation in the immune system.

Authors:  Qiutang Li; Inder M Verma
Journal:  Nat Rev Immunol       Date:  2002-10       Impact factor: 53.106

10.  Synergism between p68 RNA helicase and the transcriptional coactivators CBP and p300.

Authors:  Kari L Rossow; Ralf Janknecht
Journal:  Oncogene       Date:  2003-01-09       Impact factor: 9.867

View more
  27 in total

Review 1.  P68 RNA helicase as a molecular target for cancer therapy.

Authors:  Ting-Yu Dai; Liu Cao; Zi-Chen Yang; Ya-Shu Li; Li Tan; Xin-Ze Ran; Chun-Meng Shi
Journal:  J Exp Clin Cancer Res       Date:  2014-08-24

2.  The expression of RNA helicase DDX5 is transcriptionally upregulated by calcitriol through a vitamin D response element in the proximal promoter in SiHa cervical cells.

Authors:  Ramiro José González-Duarte; Verna Cázares-Ordoñez; Lorenza Díaz; Víctor Ortíz; Fernando Larrea; Euclides Avila
Journal:  Mol Cell Biochem       Date:  2015-08-28       Impact factor: 3.396

Review 3.  The DDX5/Dbp2 subfamily of DEAD-box RNA helicases.

Authors:  Zheng Xing; Wai Kit Ma; Elizabeth J Tran
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-12-02       Impact factor: 9.957

Review 4.  Signaling-mediated regulation of MicroRNA processing.

Authors:  Jia Shen; Mien-Chie Hung
Journal:  Cancer Res       Date:  2015-02-06       Impact factor: 12.701

5.  The DEAD box protein p68: a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis.

Authors:  M Sarkar; V Khare; K K N Guturi; N Das; M K Ghosh
Journal:  Oncogene       Date:  2015-03-09       Impact factor: 9.867

6.  miR-218 inhibits the proliferation of glioma U87 cells through the inactivation of the CDK6/cyclin D1/p21Cip1/Waf1 pathway.

Authors:  Gu Jian Jun; Gao Guang Zhong; Zhang Shi Ming
Journal:  Oncol Lett       Date:  2015-03-23       Impact factor: 2.967

Review 7.  The DEAD-box protein family of RNA helicases: sentinels for a myriad of cellular functions with emerging roles in tumorigenesis.

Authors:  Mohamed A M Ali
Journal:  Int J Clin Oncol       Date:  2021-03-03       Impact factor: 3.402

Review 8.  Cancer the'RBP'eutics-RNA-binding proteins as therapeutic targets for cancer.

Authors:  Shakur Mohibi; Xinbin Chen; Jin Zhang
Journal:  Pharmacol Ther       Date:  2019-07-11       Impact factor: 12.310

Review 9.  DEAD box RNA helicase functions in cancer.

Authors:  Frances V Fuller-Pace
Journal:  RNA Biol       Date:  2013-01-01       Impact factor: 4.652

Review 10.  DEAD-Box RNA Helicases in Cell Cycle Control and Clinical Therapy.

Authors:  Lu Zhang; Xiaogang Li
Journal:  Cells       Date:  2021-06-18       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.